Skip to main content
ONC
NASDAQ Life Sciences

BeOne Medicines Settles China Tax Audit for RMB 446 Million

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$275.34
Mkt Cap
$32.078B
52W Low
$239.25
52W High
$385.22
52W Position info
15% above low
Off High info
29% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

ONC sits 15% above its 52-week low of $239.25.

Summary

BeOne Medicines settled a statutory tax audit in China, agreeing to an income tax payment of approximately RMB 446 million, which will impact its Q2 2026 financial statements.


Key Events · Legal and Risk Events · ONC

  • China Tax Audit Concluded

    BeOne Medicines has concluded a statutory tax audit in China, resolving a previously disclosed risk related to ongoing tax audits.

  • RMB 446 Million Payment Agreed

    The company agreed to an income tax payment of approximately RMB 446 million, including surcharges and related interest, as a result of the settlement.

  • Q2 Financial Impact

    This payment is expected to be recognized in the company's U.S. GAAP financial statements for the second quarter of fiscal 2026.

  • No Administrative Penalty

    The settlement with the local tax authority did not involve any administrative penalty.


Analysis · ONC · Life Sciences

BeOne Medicines has finalized a tax audit in China, resulting in a significant payment of RMB 446 million. While the company had previously disclosed ongoing tax audit risks, this filing provides the concrete financial impact of one such settlement. The payment, which includes surcharges and interest but no administrative penalties, will be recognized in the second quarter financials, representing a material cash outflow.

How filings like this one have moved

In the 30 days to Sep 12, 2026, 29.6% of the 1872 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ONC was trading at $275.34 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $32.1B. The 52-week trading range was $239.25 to $385.22. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ONC - Latest Insights

ONC
Sep 08, 2026, 4:26 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $348.48
Real-time Price: $345.56 info
Change: -$2.92 (-0.84%) info
Market Cap: $38.792B info
ONC
Aug 05, 2026, 6:04 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $335.49
Real-time Price: $345.56 info
Change: +$10.07 (+3%) info
Market Cap: $38.792B info
ONC
Aug 05, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $335.49
Real-time Price: $345.56 info
Change: +$10.07 (+3%) info
Market Cap: $38.792B info
ONC
Aug 05, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $329.01
Real-time Price: $345.56 info
Change: +$16.55 (+5%) info
Market Cap: $38.792B info
ONC
Jul 14, 2026, 4:48 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $306.56
Real-time Price: $345.56 info
Change: +$39.00 (+13%) info
Market Cap: $38.792B info